Mendus AB (Sweden) Market Value
| IMMU Stock | SEK 8.15 0.03 0.37% |
| Symbol | Mendus |
Mendus AB 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mendus AB's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mendus AB.
| 09/28/2024 |
| 11/27/2024 |
If you would invest 0.00 in Mendus AB on September 28, 2024 and sell it all today you would earn a total of 0.00 from holding Mendus AB or generate 0.0% return on investment in Mendus AB over 60 days. Mendus AB is related to or competes with Hansa Biopharma, Xbrane Biopharma, and BioArctic. Its lead product is ilixadencel, which is in Phase II clinical trial for the treatment of kidney cancer and Phase IbII c... More
Mendus AB Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mendus AB's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mendus AB upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.91 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 35.21 | |||
| Value At Risk | (5.04) | |||
| Potential Upside | 3.94 |
Mendus AB Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mendus AB's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mendus AB's standard deviation. In reality, there are many statistical measures that can use Mendus AB historical prices to predict the future Mendus AB's volatility.| Risk Adjusted Performance | 0.0228 | |||
| Jensen Alpha | 0.0734 | |||
| Total Risk Alpha | (0.60) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | (3.04) |
Mendus AB Backtested Returns
Currently, Mendus AB is slightly risky. Mendus AB has Sharpe Ratio of 0.0052, which conveys that the firm had a 0.0052% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Mendus AB, which you can use to evaluate the volatility of the firm. Please verify Mendus AB's Downside Deviation of 2.91, mean deviation of 2.32, and Risk Adjusted Performance of 0.0228 to check out if the risk estimate we provide is consistent with the expected return of 0.022%. The company secures a Beta (Market Risk) of -0.0232, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Mendus AB are expected to decrease at a much lower rate. During the bear market, Mendus AB is likely to outperform the market. Mendus AB right now secures a risk of 4.25%. Please verify Mendus AB standard deviation, total risk alpha, treynor ratio, as well as the relationship between the jensen alpha and sortino ratio , to decide if Mendus AB will be following its current price movements.
Auto-correlation | -0.8 |
Almost perfect reverse predictability
Mendus AB has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Mendus AB time series from 28th of September 2024 to 28th of October 2024 and 28th of October 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mendus AB price movement. The serial correlation of -0.8 indicates that around 80.0% of current Mendus AB price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.8 | |
| Spearman Rank Test | -0.55 | |
| Residual Average | 0.0 | |
| Price Variance | 0.5 |
Mendus AB lagged returns against current returns
Autocorrelation, which is Mendus AB stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Mendus AB's stock expected returns. We can calculate the autocorrelation of Mendus AB returns to help us make a trade decision. For example, suppose you find that Mendus AB has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Mendus AB regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Mendus AB stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Mendus AB stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Mendus AB stock over time.
Current vs Lagged Prices |
| Timeline |
Mendus AB Lagged Returns
When evaluating Mendus AB's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Mendus AB stock have on its future price. Mendus AB autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Mendus AB autocorrelation shows the relationship between Mendus AB stock current value and its past values and can show if there is a momentum factor associated with investing in Mendus AB.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Mendus Stock Analysis
When running Mendus AB's price analysis, check to measure Mendus AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mendus AB is operating at the current time. Most of Mendus AB's value examination focuses on studying past and present price action to predict the probability of Mendus AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mendus AB's price. Additionally, you may evaluate how the addition of Mendus AB to your portfolios can decrease your overall portfolio volatility.